Renvocure 20 Tablet
Marketer
Curefuture Healthcare Pvt. Ltd
Salt Composition
Rabeprazole (20mg)
Overview Renvocure 20 Tablet
GastriCalm 20mg tablets lower stomach acid production. This medication treats acid-related disorders affecting the stomach and intestines, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome. It offers symptom relief and promotes healing. Take one GastriCalm 20mg tablet an hour before meals, ideally in the morning. Dosage depends on your condition and response; maintain consistent daily timing as directed by your physician. Continue treatment as prescribed, even if symptoms improve rapidly. Managing symptoms may involve smaller, more frequent meals and avoiding caffeine, spicy foods, and high-fat items. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and stomach ache. Report persistent or bothersome side effects to your doctor. Prolonged use (over a year) might raise fracture risk, particularly at higher doses. Discuss bone loss prevention, such as calcium and vitamin D supplements, with your doctor. Low magnesium (hypomagnesemia) may occur after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor may monitor magnesium levels. GastriCalm 20mg is unsuitable for everyone. Inform your physician about severe liver disease, HIV medication use, prior allergic reactions to similar drugs, or existing osteoporosis before starting treatment. Pregnant or breastfeeding individuals should seek medical advice before use. Avoid alcohol, as it stimulates excess stomach acid, worsening symptoms. Refrain from driving or operating machinery if dizziness or drowsiness occurs.
Uses of Renvocure 20 Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Renvocure 20 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Renvocure 20 Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
Common Side effects of Renvocure 20 Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Renvocure 20 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Renvocure 20 Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Renvocure 20 Tablet works:
Stomach acid production is decreased by Renvocure 20mg tablets, a proton pump inhibitor (PPI), providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Use of alcohol with Renvocure 20 Tablet requires careful consideration. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Using Renvocure 20 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Nursing mothers should likely avoid Renvocure 20 Tablet. Preliminary data in humans indicate potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Renvocure 20 Tablet may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Renvocure 20mg tablets pose no safety concerns for patients with renal impairment; no dosage modification is necessary.
LiverSAFE IF PRESCRIBED
Renvocure 20mg tablets pose no safety concerns for individuals with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Renvocure 20 Tablet :
Should you forget a Renvocure 20 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual regimen. Never take a double dose.
Facts to Know About Renvocure 20 Tablet
| Label | Value |
|---|---|
| Chemical Classification | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Digestive |
| Behavior Class | PPIs (proton pump inhibitors) |



